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Abstract
Introduction: COVID-19 pandemic originated in China in late 2019, the number of cases are 
increasing with 2,104,346 cases and 116,140 deaths in the United States, as of June 16, 2020. 
Pregnant women are a vulnerable population in epidemics or Pandemics. This Review is de-
signed to look in detail the severity of COVID-19 in pregnant women in comparison to non-preg-
nant women of reproductive age
Methods: Literature search on PubMed, Google Scholar, Lancet, and Web of Science were 
conducted.
Results: We have found the evidence of increased risk for severe disease and distinctive 
symptoms among pregnant women diagnosed with COVID-19 as compared to non-pregnant 
women.
Conclusions: COVID-19 presents in an atypical fashion in pregnant women with comparatively 
increased severity of symptoms, compared to COVID-19 positive non pregnant women of re-
productive age. These findings can help clinicians to recognize the risk posed by COVID-19 in 
pregnant women.
Introduction
Coronavirus disease (COVID-19) pandemic originated in Wuhan China in December, 
2019. [1] Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spread rapidly 
to most parts of the world including the USA. The number of infected people and deaths 
are still increasing. [2] SARS-CoV-2 has a similar receptor-binding structural component 
as SARS-CoV-1 which leads to possibility of similar pathogenesis as of SARS-CoV-1 in-
fection. [3] Coronavirus affects people of all ages, but it affects immunocompromised 
people and people with underlying medical conditions such as cancer, chronic kidney 
disease, COPD, obesity, serious heart conditions, sickle cell disease and type 2 diabetes 
mellitus with a higher rate of complications. [4] Physiological changes of Pregnancy 
make women more vulnerable to infections by certain intracellular pathogens includ-
ing viruses, intracellular bacteria and parasites. [5] Pregnant women represent high risk 
population during infectious disease outbreaks. Dominant effect of T- helper 2 system 
during pregnancy which protects fetus and leaves mother vulnerable to viral infections. 
[6] Pregnant women were disproportionately affected during SARS-CoV-1 epidemic re-
sulting in higher morbidity and mortality. [7]
This review discusses the presentation and severity of COVID-19 in pregnant women. 
Pregnant women can be more prone to severe manifestation of COVID-19, as depicted by 
their vulnerability to respiratory infections (5). 
The data regarding clinical characteristics and severity of COVID-19 in pregnant women 
is limited. Objective of this review is to find whether signs, symptoms and severity differ 
among pregnant and non-pregnant women with COVID-19.
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Methods
All published articles related to COVID-19’s effect on pregnancy were reviewed. Literature search on PubMed, Google 
Scholar, Lancet and Web of Science were conducted using keywords including “COVID-19, Pregnancy”, “Coronavirus 
2019, Pregnancy”, “SARS-CoV-2, Pregnancy” and “2019-nCoV, Pregnancy” from December 2019 to May 5, 2020.
Two studies were included in the analysis. [8,9] These were retrospective studies conducted in China from February to 
April 2020. These studies compared clinical course and outcomes between pregnant and non-pregnant women with 
COVID-19. 
Definitions
The severity of disease was classified as follows [8,9]:
1. Mild – Mild symptoms without radiological evidence of pneumonia.
2. Moderate – Fever and respiratory symptoms are present along with radiological findings of pneumonia.
3. Severe – Shortness of breath, with respiratory rate ≥ 30 breaths/minute, or oxygen saturation ≤ 93% at rest, or alve-
olar oxygen partial pressure/fraction of inspiration O2 (PaO2/FiO2) ≤ 300 mmHg.
4. Critical – Respiratory failure requiring mechanical ventilation, or shock, or other organ failures that required in-
tensive care unit admission.
Statistical Analysis
The differences between pregnant and non-pregnant women were analyzed using Chi-square test and p < 0.05 was 
considered statistically significant.
Results
As depicted in Table 1, a total of 148 female patients with COVID-19 were analyzed. Among these 59 patients were preg-
nant. Age range of the patients included in study was 20-40 years. Our review reported fever (37.28%), cough (37.28%) 
and dyspnea (16.95%) among pregnant women. Whereas fever (66.29%), cough (53.93%) and dyspnea (16.85%) was 
seen in non-pregnant women. Fever and cough were more common in non-pregnant women and dyspnea was compa-
rable between the two groups.
The disease severity of COVID-19 was mild/moderate more among non-pregnant (94.38%) women as compared to 
pregnant women (79.66%). Severe COVID-19 was more common in pregnant women (20.33%) as compared to non-preg-
nant (5.62%) which was statistically significant. 







Fever 81 (54.73) 22 (37.28) 59 (66.29) 0.001
Cough 70 (47.29) 22 (37.28) 48 (53.93) 0.069
Dyspnea 25(16.89) 10(16.95) 15(16.85) >0.009
Abdominal Pain 6 (4.05) 6 (10.17) 0 (0.00) 0.003
Signs, n (IQR)
Heart rate 86.65 (76.96-102.27) 88.5 (78.55-99.95) 85 (76.57-100.7) NA*
Respiratory rate 20.35 (17.85-22.35) 20.35 (18.05-21.65) 20.3 (17.6-22) NA
Severity n (%)
Mild/Moderate 131 (88.51) 47 (79.66) 84 (94.38) 0.013
Severe 17 (11.45) 12 (20.33) 5 (5.62) 0.008
Length of Hospital stay, n (IQR) 16.8 (11.41-23.13) 15.65 (11.2-23.22) 18.1 (11.42-22.8) NA
*NA=Not Applicable
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Discussion
Our review showed that pregnancy was associated with higher incidence of severe COVID-19. Most of the COVID-19 
positive pregnant patients included in the studies were symptomatic. Our review revealed that fever and cough are 
present less frequently in pregnant women. Dyspnea is present in a similar proportion among both groups. It is im-
portant to note that COVID-19 is more severe in pregnant women and the difference is significant according to the 
statistical analysis.
Pregnancy is considered an immunocompromised state mainly due to the predominance of the T helper-2(Th-2) sys-
tem. Th-2 system prevents the rejection of the “foreign” fetus. The balance shift in favor of Th-2, which decreases the 
functionality of T helper-1 which are responsible for clearing pathogens, especially viruses. Th-1 lymphocytes produce 
cytokines which are microbicidal and proinflammatory. This increases morbidity by increasing maternal susceptibility 
to intracellular pathogen and can lead to increase severity of infection. [6]
Our review showed pregnant women had less symptoms as compared to non-pregnant women which can cause delay 
in diagnosis and contact tracing, which can lead to unchecked viral shedding and community transmission. [6] 
Symptoms like shortness of breath can be difficult to distinguish from pathological dyspnea. In pregnancy, physiologi-
cal dyspnea is common due to increased maternal oxygen demand and higher fetal oxygen consumption. Progesterone 
acts as trigger of the primary respiratory center by increasing the sensitivity of respiratory center to carbon dioxide. 
[10] Also, gravid uterus results in decreased lung capacity starting at mid-second trimester and progressively decreas-
ing towards term, which can cause shortness of air. [11] During pregnancy, gestational rhinitis is also common due to 
estrogen-mediated hyperemia of the nasopharynx which may mask COVID-19 symptoms. 
A recent case series of 9 women showed that symptoms of COVID-19 in pregnant women were similar to that of 
non-pregnant women. Most common symptoms were fever, cough, myalgia, and sore throat. Most common lab finding 
was lymphopenia. [12] 
In the CDC reported data of 8,207 pregnant women, symptoms were reported among 65.2% of pregnant women and 
90% of non-pregnant women. Cough (>50%) and shortness of breath (30%) was present in similar number among preg-
nant and non-pregnant women but pregnant women reported lower incidence of headaches, muscle aches, fever, chills, 
and diarrhea than non-pregnant women. 
Among 8,207 COVID-19 positive pregnant women, approximately 31.5% of pregnant women were reported to be hospi-
talized compared with 5.8% of non-pregnant women. After adjusting for age, underlying medical conditions and race, 
pregnant women were significantly more likely to be admitted to the intensive care unit (ICU) (ARR = 1.5, CI= 1.2–1.8) 
and receive mechanical ventilation (ARR = 1.7, CI = 1.2–2.4). Sixteen (0.2%) COVID-19 related deaths were reported 
among pregnant women and 208 (0.2%) such deaths were reported among non-pregnant women (ARR = 0.9, CI = 
0.5–1.5). [13] 
These findings suggest that among women of reproductive age with COVID-19, pregnant women are more likely to be 
hospitalized and at increased risk for ICU admission and mechanical ventilation compared with non-pregnant women, 
but their risk for death is similar.
In conclusion, our data suggest that COVID-19 during pregnancy is associated with high risk for severe disease and a 
distinctive symptom profile that may delay diagnosis. Therefore, routine SARS-CoV-2 screening in pregnancy will be 
beneficial in making early diagnosis and facilitate early treatment. Caution should be practiced by pregnant women by 
regularly washing hands, using hand sanitizer, face mask and minimizing the exposure to symptomatic people. Tele-
health is a viable option in pregnant women for minimizing the exposure wherever possible. It is necessary to follow 
pregnant women pre and post-delivery to ensure proper care and education regarding isolation, breastfeeding and 
proper care of pregnant woman and the infant. There is need for studies to look into overall impact and long-term out-
comes of pregnant women affected by COVID-19.
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